Two Growth Funds That Shrugged Off the Poor Decade
The past 10 years knocked many large-growth funds down for the count, but these two came out swinging.
The past 10 years knocked many large-growth funds down for the count, but these two came out swinging.
Large-growth funds' returns haven't looked bad in the past year, but their 10-year results are still downright ugly. The group is down almost 2% annualized for the decade versus large value and large blend's respective 3% and 1% gains. That's because large growth suffered more than other big-cap funds during the decade's two bear markets and the 10-year period now excludes large-growth stocks' late-1990s' glory days.
Some funds deftly navigated the decade, though. You can find them in just a few steps with the Premium Screener. To begin, focus on reasonably priced large-growth funds that are open to new investment. Next, set the screen to pull funds that gained at least 3% annualized, or more than the typical large-value fund, over the decade. Also limit the field to managers with tenures of 10 years or more to ensure current management is responsible for the performance.
Lastly, screen for funds with a Best Fit Index R-squared of 80 or above to help eliminate funds that haven't stayed firmly rooted in large-growth territory. (Morningstar designates the Best Fit Index as the one that shows the highest correlation with a fund over the most recent 36 months, and R-squared measures the percentage of a fund's movements explained by the movements of this index, with 100 indicating that they're perfectly in sync.)
As of May 3, 2010, the screen turned up two funds. To run it yourself, click here.
When he took over Fidelity Contrafund (FCNTX) in 1990, Will Danoff focused on small caps and mid-caps. More than a decade ago, Danoff began venturing into larger fare to accommodate the fund's growing asset base, and it has been firmly planted in large-growth territory ever since. Danoff looks for mid- and large-cap companies with strong and improving earnings. Although the fund has owned between 300 and 600 stocks over the past decade, Danoff adroitly uses Fidelity's army of analysts to keep tabs on them all. And he's found that staying on top of smaller firms helps guide his stock-picking among the industry titans that grab larger positions in this portfolio. The fund's 3.8% annualized 10-year return is a result of deft stock-picking and portfolio construction.
T. Rowe Price Spectrum Growth (PRSGX) is different, but just as intriguing. The fund of funds owns 11 T. Rowe Price funds, including small-cap and value-focused offerings, but has retained a large-growth tilt thanks to big helpings of T. Rowe Price Growth Stock (PRGFX) and T. Rowe Price Blue Chip Growth (TRBCX). The fund provides access to some of the firm's best offerings, four of which are Analyst Picks. Its asset-allocation committee of veteran managers also has added long-term value by shifting assets among the funds. It landed in the top quartile in every calendar year of the past decade except for 2008, and its 3.4% annualized return over the past 10 years topped more than 97% of its peers.
Don't have a Premium Membership? You can still use our Premium Fund Screener by taking a free, 14-day trial.
Karin Anderson does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.